Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

Wednesday’s trading has closed, but GRFS is being traded in the after-hours session. After-Hours quote »
14.56
Delayed Data
As of 4:00pm ET
 -0.01 / -0.07%
Today’s Change
14.07
Today|||52-Week Range
18.04
-10.12%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close14.57
Today’s open14.69
Day’s range14.51 - 14.92
Volume678,992
Average volume (3 months)1,124,523
Market cap$3.8B
Dividend yield2.50%
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+34.75%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.60%
Revenue growth (last year)+21.57%
P/E ratio--
Price/Sales2.63
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-2.17-7.47%
OPKOPKO Health Inc+0.09+1.16%
ALKSAlkermes Plc+0.77+2.65%
ANACAnacor Pharmaceutica...+0.55+0.82%
Data as of 4:00pm ET, 02/10/2016

Financials

Next reporting dateFebruary 29, 2016
EPS forecast (this quarter)$0.28
Annual revenue (last year)$4.4B
Annual profit (last year)$621.4M
Net profit margin14.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts

Partner Offers